SIRT1 Inhibits Bovine Cartilage ECM Degradation and Apoptosis by
Activating Nrf2/HO-1 and Inhibiting NF-κB Pathways
Zongsheng Qiu 1†, Jingjing Qi1†, Xiaoyan Guo
1, Tiantian Gao 1, Hui Bai 2, Chengwei
Wei 1, Zhiheng Zhang 2, Yanan Li 1,3,
Yuhui Ma 3, Jiantao Zhang 1 and Tianwen Ma
1,3*
1Heilongjiang
Key Laboratory for Laboratory Animals and Comparative Medicine,
College of Veterinary Medicine, Northeast Agricultural University,
Harbin 150030, China; 2 College of Veterinary Medicine,
Inner Mongolia Agricultural University, Hohhot 010000, China; 3
Zhaosu County Xiyu Horse Industry Co., Ltd., Zhaosu 835500, China. †
Zongsheng Qiu and Jingjing Qi contributed equally to this work.
This study explored the potential mechanism of SIRT1 in bovine osteoarthritis
(OA). In vivo experiments evaluated the severity of damage to bovine
tarsal cartilage tissue through pathological staining and Mankin scoring. When
compared with healthy bovines, cartilage in OA-affected bovines displayed ECM
degradation and increased Mankin scores (P<0.01). In the cartilage of
OA-affected cattle, the protein expression of inflammatory factors (TNF-α,
IL-1β, COX-2) and ECM degradation markers (MMP-3, MMP-13) was increased
(P<0.05), the expression levels of key pathway proteins (including SIRT1,
nuclear Nrf2 and HO-1) were decreased (P<0.05), and the expression of nuclear
p65 and p-IκBα was upregulated (P<0.05). In vitro studies, we developed a
bovine primary chondrocyte inflammation model using 10ng/mL IL-1β. IL-1β
treatment significantly upregulated the expression levels of ECM degradation
markers in chondrocytes (P<0.01). Transmission electron microscopy revealed
mitochondrial ultrastructural damage, and flow cytometry indicated an apoptosis
rate of 38.1%. ML334 treatment significantly enhanced the levels of nuclear
Nrf2, HO-1, and Bcl-2 (P<0.05), while simultaneously decreasing nuclear p65,
BAX, Cleaved caspase-3, and ECM degradation markers (P<0.05). JSH-23 treatment
successfully downregulated nuclear p65 and ECM degradation marker levels
(P<0.05). Treatment with the SIRT1 agonist SRT2104 not only increased the level
of SIRT1, nuclear Nrf2, and HO-1 (P<0.05), but also effectively attenuated the
expression of nuclear p65 (P<0.05). This experiment strongly supports the claim
that SIRT1 effectively protects bovine cartilage ECM from degradation and
apoptosis through a dual mechanism of action (activation of the Nrf2/HO-1
pathway and inhibition of the NF-κB pathway).
To Cite This Article:
Qiu Z, Qi J, Guo X, Gao T, Bai H, Wei C, Zhang Z, Li Y, Ma Y, Zhang J and Ma T,
2026. SIRT1 inhibits bovine cartilage ECM degradation and apoptosis by
activating Nrf2/HO-1 and inhibiting NF-κB pathways. Pak Vet J, 46(2): 460-467.
http://dx.doi.org/10.29261/pakvetj/2026.034